Skip to main content
Log in

Elektrische Isolation des linken Vorhofohrs

Nutzen und Risiko

Electrical isolation of the left atrial appendage

Benefits and risks

  • Schwerpunkt
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Das linke Vorhofohr (LAA) ist eine Ausstülpung aus dem linken Vorhof (LA), die anatomische und physiologische Abweichungen vom linken Atrium aufweist. Verschiedene LAA-Morphologien werden unterschieden. Das LAA ist nicht nur hauptverantwortlich für intrakardiale Thromben, sondern auch Ursprungsort von Triggern, welche atriale Tachyarrhythmien bzw. Vorhofflimmern initiieren können. Insbesondere bei Patienten mit persistierendem oder lang anhaltend persistierendem Vorhofflimmern kann durch eine elektrische Isolation des LAA zusätzlich zur Pulmonalvenenisolation die klinische Erfolgsrate möglicherweise verbessert werden. Allerdings zeigte sich, dass eine elektrische LAA-Isolation auch unter Therapie mit oralen Antikoagulanzien in Abhängigkeit von der angewandten Ablationsstrategie zu einer erhöhten Rate von LAA-Thromben bzw. Thrombembolien führen kann. Somit sollte nach LAA-Isolation ein Vorhofohrverschluss mit dem Patienten diskutiert werden.

Abstract

The left atrial appendage (LAA) is an extension originating from the body of the left atrium. The LAA is derived from the primary atrium and shows anatomical and physiological deviations from the left atrium. Different LAA morphologies exist. The LAA is not only the most frequent origin of intracardiac thrombi, it also frequently shows triggers responsible for the initiation or maintenance of atrial tachyarrhythmia and atrial fibrillation (AF). Isolation of the LAA using radiofrequency energy in addition to isolation of the pulmonary vein has recently gained importance due to the potential for increasing the clinical success rates, particularly in patients with persistent and long-standing persistent AF; however, after LAA isolation the incidence of LAA thrombi and systemic thromboembolisms might be increased even under treatment with oral anticoagulants, depending on the ablation strategy used. Thus, mechanical occlusion of the LAA should be discussed with patients after electrical isolation of the LAA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 3

Literatur

  1. Di Biase L, Burkhardt JD, Mohanty P et al (2010) Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 122:109–118

    Article  PubMed  Google Scholar 

  2. Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. New Engl J Med 306:1018–1022

    Article  CAS  PubMed  Google Scholar 

  3. Schnabel RB, Wilde S, Wild PS et al (2012) Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 109:293–299

    PubMed  PubMed Central  Google Scholar 

  4. Anonymous (1994) Risk factors for stroke an efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 154:1449–1457

  5. Haissaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666

    Article  CAS  PubMed  Google Scholar 

  6. Rillig A, Lin T, Schmidt B et al (2016) Experience matters: long-term results of pulmonary vein isolation using a robotic navigation system for the treatment of paroxysmal atrial fibrillation. Clin Res Cardiol 105:106–116

    Article  PubMed  Google Scholar 

  7. Ouyang F, Tilz R, Chun J et al (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 122:2368–2377

    Article  PubMed  Google Scholar 

  8. Linhart M, Bellmann B, Mittmann-Braun E et al (2009) Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. J Cardiovasc Electrophysiol 2:1343–1348

    Article  Google Scholar 

  9. Tilz RR, Rillig A, Thum AM et al (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5‑year outcomes of the hamburg sequential ablation strategy. J Am Coll Cardiol 60:1921–1929

    Article  PubMed  Google Scholar 

  10. Verma A, Jiang CY, Betts TR et al (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812–1822

    Article  PubMed  Google Scholar 

  11. Rillig A, Tilz RR, Lin T et al (2016) Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol 9:e003461

    Article  PubMed  Google Scholar 

  12. Rillig A, Tilz RR, Lin T et al (2016) Response by Rillig et al to letter regarding article, „An unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias“. Circ Arrhythm Electrophysiol 9:e004556. doi:10.1161/CIRCEP.116.004556

    Article  PubMed  Google Scholar 

  13. Calvo N, Salterain N, Arguedas H et al (2015) Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Europace 17:1533–1540

    Article  PubMed  Google Scholar 

  14. Rillig A, Heeger CH, Kuck KH, Tilz RR (2015) Interventional stroke prophylaxis: endocardial and epicardial left atrial appendage closure. Herz 40:50–59

    Article  CAS  PubMed  Google Scholar 

  15. Naksuk N, Padmanabhan D, Yogeswaran V, Asirvatham SJ (2016) Left atrial appendage: embryology, anatomy, physiology, arrhythmia and therapeutic intervention. JACC Clin Electrophysiol 2:403–412

    Article  Google Scholar 

  16. Beigel R, Wunderlich NC, Ho SY et al (2014) The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging 7:1251–1265

    Article  PubMed  Google Scholar 

  17. Panikker S, Jarman JW, Virmani R et al (2016) Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol 9:e004652. doi:10.1161/circep.116.004652

    Article  PubMed  Google Scholar 

  18. Benussi S, Mazzone P, Maccabelli G et al (2011) Thoracoscopic appendage exclusion with an atriclip device as a solo treatment for focal atrial tachycardia. Circulation 123:1575–1578

    Article  PubMed  Google Scholar 

  19. Yamada T, Murakami Y, Yoshida Y et al (2007) Electrophysiologic and electrocardiographic characteristics and radiofrequency catheter ablation of focal atrial tachycardia originating from the left atrial appendage. Heart Rhythm 4:1284–9121

    Article  PubMed  Google Scholar 

  20. Yang Q, Ma J, Zhang S, Hu JQ, Liao ZL (2012) Focal atrial tachycardia originating from the distal portion of the left atrial appendage: characteristics and long-term outcomes of radiofrequency ablation. Europace 14:254–260

    Article  PubMed  Google Scholar 

  21. Yamada T, McElderry HT, Allison JS, Kay GN (2008) Focal atrial tachycardia originating from the epicardial left atrial appendage. Heart Rhythm 5:766–767

    Article  PubMed  Google Scholar 

  22. Zhao Y, Di Biase L, Trivedi C et al (2016) Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm 13:141–149

    Article  PubMed  Google Scholar 

  23. Hocini M, Shah AJ, Nault I et al (2011) Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm 8:1853–1861

    Article  PubMed  PubMed Central  Google Scholar 

  24. Di Biase L, Burkhardt JD, Mohanty P et al (2016) Left atrial appendage isolation in patients with long-standing persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol 68:1929–1940

    Article  PubMed  Google Scholar 

  25. Rillig A, Schmidt B, Feige B et al (2013) Left atrial isthmus line ablation using a remote robotic navigation system: feasibility, efficacy and long-term outcome. Clin Res Cardiol 102:885–893

    Article  PubMed  Google Scholar 

  26. Reissmann B, Rillig A, Wissner E et al (2017) Durability of wide-area left atrial appendage isolation: results from extensive catheter ablation for treatment of persistent atrial fibrillation. Heart Rhythm 14(3):314. doi:10.1016/j.hrthm.2016.11.009

    Article  PubMed  Google Scholar 

  27. Bordignon S, Perrotta L, Fürnkranz A et al (2015) Durable single shot cryoballoon isolation of the left atrial appendage followed by percutaneous left atrial appendage closure. Circ Arrhythm Electrophysiol 8:751–752

    Article  PubMed  Google Scholar 

  28. Han FT, Bartus K, Lakkireddy D et al (2014) The effects of LAA ligation on LAA electrical activity. Heart Rhythm 11:864–870

    Article  PubMed  PubMed Central  Google Scholar 

  29. Afzal MR, Kanmanthareddy A, Earnest M et al (2015) Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm 12:52–59

    Article  PubMed  Google Scholar 

  30. Starck CT, Steffel J, Emmert MY et al (2012) Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg 15:416–418

    Article  PubMed  PubMed Central  Google Scholar 

  31. Lee RJ, Bartus K, Yakubov SJ (2010) Catheter-based left atrial appendage (LAA) ligation for the pre-vention of embolic events arising from the LAA: initial experience in a canine model. Circ Cardiovasc Interv 3:224–229

    Article  PubMed  Google Scholar 

  32. Bartus K, Morelli RL, Szczepanski W et al (2014) Anatomic analysis of the left atrial appendage after closure with the LARIAT device. Circ Arrhythm Electrophysiol 7:764–767

    Article  PubMed  Google Scholar 

  33. Lakkireddy D, Mahankali A, Kanmanthareddy A et al (2015) Left atrial appendage ligation and ablation for persistent atrial fibrillation: the LAALA-AF Registry. J Am Coll Cardiol Ep 1:153–160

    Google Scholar 

  34. Bartus K, Gafoor S, Tschopp D et al (2016) Left atrial appendage ligation with the next generation LARIAT(+) suture delivery device: Early clinical experience. Int J Cardiol 215:244–247. doi:10.1016/j.ijcard.2016.04.005

    Article  PubMed  Google Scholar 

  35. Bartus K, Han FT, Bednarek J et al (2013) Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 62:108–118

    Article  PubMed  Google Scholar 

  36. Lee RJ, Lakkireddy D, Mittal S et al (2015) Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and design. Am Heart J 170:1184–1194

    Article  PubMed  Google Scholar 

  37. Mokracek A, Kurfirst V, Bulava A et al (2015) Thoracoscopic occlusion of the left atrial appendage. Innovations (Phila) 10:179–182

    Article  Google Scholar 

  38. Romanov A, Pokushalov E, Elesin D et al (2016) Effect of left atrial appendage excision on procedure outcome in patients with persistent atrial fibrillation undergoing surgical ablation. Heart Rhythm 13:1803–1809

    Article  PubMed  Google Scholar 

  39. Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962

    Article  PubMed  Google Scholar 

  40. Whitlock R, Healey J, Vincent J et al (2014) Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg 3:45–54

    PubMed  PubMed Central  Google Scholar 

  41. Zhang J, Tang C, Zhang Y, Su XI (2015) Electrophysiologic and clinical consequences of left atrial anterior wall linear ablation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. doi:10.1111/jce.12713

    PubMed Central  Google Scholar 

  42. Bellmann B, Rillig A, Leistner D et al (2016) Left atrial appendage closure in a patient with left atrial appendage thrombus using a novel fish ball technique. Int J Cardiol. doi:10.1016/j.ijcard.2016.12.141

    PubMed  Google Scholar 

  43. Meincke F, Kreidel F, von Wedel J et al (2015) Percutaneous left atrial appendage closure in patients with left atrial appendage thrombus. EuroIntervention 10:1208

    Article  PubMed  Google Scholar 

  44. Walker DT, Phillips KP (2015) Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience. Europace 17:1402–1406

    Article  PubMed  Google Scholar 

  45. Heeger CH, Rillig A, Lin T et al (2015) Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices. Heart Rhythm 12:1524–1531

    Article  PubMed  Google Scholar 

  46. Turagam MK, Lavu M, Afzal MR et al (2016) Catheter Ablation for Atrial Fibrillation in Patients with Watchman® Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry. J Cardiovasc Electrophysiol 12. doi:10.1111/jce.13148

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Rillig MD.

Ethics declarations

Interessenkonflikt

A. Rillig received travel grants from Biosense, Hansen Medical and St. Jude Medical and lecture fees from St. Jude Medical and Boehringer Ingelheim and participated at the Boston scientific EP-fellowship. B. Bellmann participated at the Boston scientific EP-fellowship. R.R. Tilz received research grants from Hansen, Abbot, travel Grants: Abbot, Biosense Webster, Medtronic, Daiichi Sankyo, Sentrheart and speaker’s bureau/proctor honoraria: Biosense Webster, Medtronic, Biotronik, Pfizer, Abbot, Bristol-Myers Squibb; Bayer, Sanofi Aventis, AstraZeneca.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellmann, B., Tilz, R.R. & Rillig, A. Elektrische Isolation des linken Vorhofohrs. Herz 42, 364–372 (2017). https://doi.org/10.1007/s00059-017-4559-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-017-4559-0

Schlüsselwörter

Keywords

Navigation